4//SEC Filing
JORDEN DAVID EMERSON 4
Accession 0001437749-26-000431
CIK 0001091596other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 7:25 PM ET
Size
8.4 KB
Accession
0001437749-26-000431
Insider Transaction Report
Form 4
JORDEN DAVID EMERSON
Director10% Owner
Transactions
- Exercise/Conversion
Common Stock
2026-01-01$0.40/sh+125,000$50,000→ 2,071,755 total - Tax Payment
Common Stock
2026-01-01$1.97/sh−25,381$50,001→ 2,046,374 total - Exercise/Conversion
Option to purchase common stock
2018-12-31−125,000→ 0 totalExercise: $0.40From: 2018-12-31Exp: 2026-01-01→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]Represents a net exercise of outstanding stock options. The reporting person received 99,619 shares of common stock on the net exercise of option to purchase 125,000 shares of common stock. The issuer withheld 25,381 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.97.
Documents
Issuer
Nuo Therapeutics, Inc.
CIK 0001091596
Entity typeother
Related Parties
1- filerCIK 0001313516
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 7:25 PM ET
- Size
- 8.4 KB